Cholesterol and Mevalonate: Two Metabolites Involved in Breast Cancer Progression and Drug Resistance through the ERRα Pathway

Breast cancer is the second greatest cause of cancer-related death in women. Resistance to endocrine treatments or chemotherapy is a limiting drawback. In this context, this work aims to evaluate the effects of cholesterol and mevalonate during tumor progression and their contribution in the onset o...

Descripción completa

Detalles Bibliográficos
Autores principales: Brindisi, Matteo, Fiorillo, Marco, Frattaruolo, Luca, Sotgia, Federica, Lisanti, Michael P., Cappello, Anna Rita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465765/
https://www.ncbi.nlm.nih.gov/pubmed/32751976
http://dx.doi.org/10.3390/cells9081819

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465765/
https://www.ncbi.nlm.nih.gov/pubmed/32751976
http://dx.doi.org/10.3390/cells9081819

Ejemplares similares